Soluble Fas Ligand: Is It a Critical Mediator of Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome?-Reference-Cited by-同舟云学术

Soluble Fas Ligand: Is It a Critical Mediator of Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome?

Published:2007-04 Issue:4 Volume:127 Page:744-745
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Murata Junko,Abe Riichiro

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference9 articles.

1. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand;Abe;Am J Pathol,2003

2. Medical genetics: a marker for Stevens–Johnson syndrome;Chung;Nature,2004

3. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis;Nassif;J Invest Dermatol,2002

4. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis;Paquet;Arch Dermatol,1994

5. Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis;Shiota;Res Commun Mol Pathol Pharmacol,1998

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation;Allergy;2022-12-17

2. Ask Not What AI Can Do to Us, but What We Can Do with AI;The Journal of Allergy and Clinical Immunology: In Practice;2022-01

3. Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy;International Journal of Medical Sciences;2021

4. Responsiveness to i.v. immunoglobulin therapy in patients with toxic epidermal necrolysis: A novel pharmaco‐immunogenetic concept;The Journal of Dermatology;2020-09-15

5. Necrólisis epidérmica tóxica en paciente infectado por virus de inmunodeficiencia humana;MedUNAB;2012-03-31